Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy

Abstract Background Corticosteroids are routinely utilized to alleviate edema in patients with intracranial lesions and are first-line agents to combat immune-related adverse events (irAEs) that arise with immune checkpoint blockade treatment. However, it is not known if or when corticosteroids can...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Amber J. Giles, Marsha-Kay N. D. Hutchinson, Heather M. Sonnemann, Jinkyu Jung, Peter E. Fecci, Nivedita M. Ratnam, Wei Zhang, Hua Song, Rolanda Bailey, Dionne Davis, Caitlin M. Reid, Deric M. Park, Mark R. Gilbert
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2018-06-01
Serie:Journal for ImmunoTherapy of Cancer
Soggetti:
Corticosteroids
Immunotherapy
Glioma
Checkpoint blockade
Dexamethasone
Accesso online:http://link.springer.com/article/10.1186/s40425-018-0371-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi